BrainCool AB (publ) increases revenues by 343% during the first three quarters of 2019

BrainCool AB (publ) increases revenues during the first 9 months of 2019 to 3,1 MSEK, a 343% increase compared to the corresponding period previous year (0,7 MSEK).

CEO Martin Waleij comments;

-        The main part of the revenues come from the European operations, which in addition also shows a solid order intake so far in the fourth quarter. We also expect that revenues from the US market will increase.

BrainCool reports the third quarter financials on November 29, following the current share issue subscription period, thus the timeline of the capitalization is not affected.  

This information is information that BrainCool (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out herein, on October 28, 2019. 

For more information

Martin Waleij - CEO                                                               
+46 - 733 -93 70 76                                                                                          
E-mail: martin.waleij@braincool.se                       

About BrainCool AB (publ)

BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. The company focuses on two business segments, Brain Cooling and Pain Management. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Spotlight Stock Market.